Voloridge Investment Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,936
| Closed | -$173K | – | 1560 |
|
|
2023
Q1 | $173K | Sell |
15,936
-29,877
| -65% | -$324K | ﹤0.01% | 1319 |
|
|
2022
Q4 | $514K | Buy |
+45,813
| New | +$514K | ﹤0.01% | 1268 |
|
|
2022
Q3 | – | Sell |
-252,845
| Closed | -$2.29M | – | 1615 |
|
|
2022
Q2 | $2.29M | Sell |
252,845
-82,261
| -25% | -$745K | 0.01% | 974 |
|
|
2022
Q1 | $3.2M | Buy |
335,106
+161,036
| +93% | +$1.54M | 0.02% | 797 |
|
|
2021
Q4 | $1.92M | Sell |
174,070
-46,824
| -21% | -$517K | 0.01% | 1084 |
|
|
2021
Q3 | $1.64M | Buy |
+220,894
| New | +$1.64M | 0.01% | 1120 |
|
|
2020
Q4 | – | Sell |
-34,899
| Closed | -$516K | – | 1558 |
|
|
2020
Q3 | $516K | Sell |
34,899
-26,192
| -43% | -$387K | ﹤0.01% | 1081 |
|
|
2020
Q2 | $1.28M | Buy |
+61,091
| New | +$1.28M | 0.01% | 765 |
|
|
2020
Q1 | – | Sell |
-29,102
| Closed | -$753K | – | 1385 |
|
|
2019
Q4 | $753K | Buy |
+29,102
| New | +$753K | 0.01% | 723 |
|